Expert Interview
Examination of Eton Pharmaceuticals’ Rezipres - Ephedrine Hydrochloride Injection for hypotension occurring in the setting of anesthesia
Ticker(s): ETONAn anesthesiologist / anesthesia specialist with experience in clinically important hypotension occurring in the setting of anesthesia, and knowledge about Rezipres - Ephedrine Hydrochloride Injection
Please tell us about your clinical experience. How many surgeries do you attend, and how often do you have to deploy hypotension treatment? What is the main go-to choice for those cases, and why?
What benefits are present in using Eton's ready-to-use injectable product, vs competition?
Added By: catalin_adminCan you explain to us the mechanism of action of Ephedrine Injections, its role in increasing the activity of the α and β adrenergic receptors, how it acts as a bronchodilator?
What meaningful, real case improvements can be seen with the use of this sulfite-free formulation?
What are the pros and cons, and what would you consider using more, between Rezipres and an Ephedrine Sulfate Injection FDA Approved option, like Nevakar’s 50mg/10 ml single use vial, or Nexus Pharma’s Emerphed?
How often do serious side effects occur after use of Ephedrine injections?
How likely is the company to have manufacturing or inspection issues that could delay product launch on the market?
How likely would you be to be using Rezipres from now on?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
